Home | Laws | Print Page | Contact Us | Sign In | Register
News: Industry News

FDA Approves Buprenorphine Product in Opioid Epidemic

Thursday, December 7, 2017  
Posted by: AATA Staff
Share |
The US Food and Drug Administration announced this week that they have approved an injectable buprenorphine for opioid addiction. Read More

Contact Us

Behavioral Health Association of Providers
11835 W Olympic Blvd., Suite 1090
Los Angeles, CA 90064


Membership Agreement
Code of Ethics
Privacy Policy

About BHAP

Behavioral Health Association of Providers helps you feel confident that you comply with changing legal regulations and industry best practices while reinforcing your reputation within your network of ethical business practitioners.

Connect With Us